Gadd45 in modulation of solid tumors and leukemia

Advances in Experimental Medicine and Biology

Volumn 793, Issue , 2013, Pages 21-33

  Hoffman, Barbara ^a   Liebermann, Dan A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD135 ANTIGEN; ENDOCRINE DISRUPTOR; GADD45A PROTEIN; GADD45B PROTEIN; GADD45G PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN 2; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELLULAR STRESS RESPONSE; CHRONIC MYELOID LEUKEMIA; ENZYME ACTIVATION; GADD45 GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE SILENCING; GENE STRUCTURE; GENETIC ASSOCIATION; HEMATOPOIESIS; LEUKEMIA; MALIGNANT TRANSFORMATION; ONCOGENE H RAS; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; SENESCENCE; SOLID TUMOR; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE;

EID: 84934444231     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-8289-5_2     Document Type: Article

References (62)

1. Abdollahi A, Lord KA, DA Hoffman-Liebermann L (1991) Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines. Oncogene 6:165-167.
2. Amente S, Zhang J, Lavadera ML et al (2011) Myc and PI3K/AKT signaling cooperatively repress FOXO3a-dependent PUMA and Gadd45a gene expression. Nucleic Acids Res 39:9498-9507.
3. Bahar A, Bicknell JE, Simpson DJ, Clayton RN, Farrell WE (2004) Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation. Oncogene 23:936-944.
4. Beadling C, Johnson KW, Smith KA (1993) Isolation of interleukin 2-induced immediate-early genes. Proc Natl Acad Sci USA 90:2719-2723.
5. Betancourt AM, Mobley JA, Russo J, Lamartiniere CA (2010) Proteomic analysis in mammary glands of rat offspring exposed in utero to bisphenol A. J Proteomics 73:1241-1253.
6. Carrier F, Smith ML, Bae I, Kilpatrick KE, Lansing TJ, Chen CY, Engelstein M, Friend SH, Henner WD, Gilmer TM, Kastan MB, Fornace AJ Jr (1994) Characterization of human Gadd45, a p53-regulated protein. J Biol Chem 269:32672-32677.
7. Casals-Casas C, Desvergne B (2011) Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 73:135-162.
8. Drayton S, Peters G (2002) Immortalization and transformation revisited. Curr Opin Genet Dev 12:98-104.
9. Fialkow PJ, Gartler SM, Yoshida A (1967) Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci USA 58:1468-1471.
10. Guo W, Dong Z, Chen Z, Kuang G, Yang Z (2013) Methylation-mediated repression of Gadd45a and Gadd45g expression in gastric cardia adenocarcinoma. Int J Cancer. doi: 10.1002/ijc.28223.
11. Gupta M, Gupta S, Balliet AG, Hollander MC, Fornace AJ, Hoffman B, Liebernmann DA (2005) Hematopoietic cells from Gadd45a and Gadd45b deficient mice are sensitized to genotoxicstress induced apoptosis. Oncogene 24:7170-7179.
12. Gupta M, Gupta S, Hoffman B, Liebermann DA (2006a) Gadd45a and gadd45b protect hematopoietic cells from ultraviolet radiation induced apoptosis via distinct signaling pathways. J Biol Chem 281:17552-17558.
13. Gupta S, Gupta M, Hoffman B, Liebermann DA (2006b) Hematopoietic cells from gadd45a deficient and gadd45b deficient mice exhibit impaired stress responses to acute stimulation with cytokines, myeloablation, and inflammation. Oncogene 25:5537-5546.
14. Higgs MR, Lerat H, Pawlotsky JM (2010) Downregulation of Gadd45beta expression by hepatitis C virus leads to defective cell cycle arrest. Cancer Res 70:4901-4911.
15. Hildesheim J, Fornace AJ Jr (2002) Gadd45a: an elusive yet attractive candidate gene in pancreatic cancer. Clin Cancer Res 8:2475-2479.
16. Hingorani SR, Wang L, Multani AS, Combs C et al (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7:469-483.
17. Hoffman B, Liebermann DA (2009) Gadd45 modulation of intrinsic and extrinsic stress responses in myeloid cells. J Cell Physiol 218:26-31.
18. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace AJ Jr (1999) Genomic instability in Gadd45a-deficient mice. Nat Genet 23:176-184.
19. Ikeda A, Shankar DB, Watanabe M, Tamanoi F et al (2006) Molecular targets and the treatment of myeloid leukemia. Mol Genet Metab 88:216-224.
20. Jenkins S, Betancourt AM, Wang J, Lamartiniere CA (2012) Endocrine-active chemicals in mammary cancer causation and prevention. J Steroid Biochem Mol Biol 129:191-200.
21. Kawaguchi H, Miyoshi N, Miyamoto Y, Souda M et al (2009) Effects of fetal exposure to diethylstilbestrol on mammary tumorigenesis in rats. J Vet Med Sci 71:1599-1608.
22. Knight AW, Birrell L, Walmsley RM (2009a) Development and validation of a higher throughput screening approach to genotoxicity testing using the GADD45a-GFP GreenScreen HC assay. J Biomol Screen 14:16-30.
23. Knight AW, Little S, Houck K, Dix D et al (2009b) Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals. Regul Toxicol Pharmacol 55:188-199.
24. Lamartiniere CA, Moore JB, Brown NM et al (1995) Genistein suppresses mammary cancer in rats. Carcinogenesis 16:2833-2840.
25. Leach SD (2004) Mouse models of pancreatic cancer: the fur is finally flying. Cancer Cell 5:7-11.
26. Li Y, Qian H, Li X, Wang H, Yu J, Liu Y, Zhang X, Liang X, Fu M, Zhan Q, Lin C (2009) Adenoviral-mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell. J Gene Med 11:3-13.
27. Liebermann DA, Hoffman B (1998) MyD genes in negative growth control. Oncogene 17:3319-3330.
28. Liebermann D, Tront JS, Sha X, Mukherjee K, Mohamed-Hadley A, Hoffman B (2011) Gadd45 stress sensors in malignancy and leukemia. Crit Rev Oncog 16:129-140.
29. Lundberg AS, Hahn WC, Gupta P, Weinberg RA (2000) Genes involved in senescence and immortalization. Curr Opin Cell Biol 12:705-709.
30. Michaelis KA, Knox AJ, Xu M, Kiseljak-Vassiliades K, Edwards MG, Geraci M, Kleinschmidt-DeMasters BK, Lillehei KO, Wierman ME (2011) Identification of growth arrest and DNAdamage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. Endocrinology 152:3603-3613.
31. Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S (1994) Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 83:2248-2254.
32. Murrill WB, Brown NM, Zhang JX, Manzolillo PA et al (1996) Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carclnogenesis 17:1451-1457.
33. Na YK, Lee SM, Hong HS, Kim JB, Park JY, Kim DS (2010) Hypermethylation of growth arrest DNA-damage-inducible gene 45 in non-small cell lung cancer and its relationship with clinicopathologic features. Mol Cells 30:89-92.
34. Nowell PC, Hungerford DA (1960) Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 25:85-109.
35. Parcells BW, Ikeda AK, Simms-Waldrip T, Moore TB, Sakamoto KM (2006) FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia. Stem Cells 24:1174-1184.
36. Parikh C, Subrahmanyam R, Ren R (2007) Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice. Cancer Res 67:7139-7146.
37. Perugini M, Kok CH, Brown AL, Wilkinson CR, Salerno DG, Young SM, Diakiw SM, Lewis ID, Gonda TJ, D'Andrea RJ (2009) Repression of Gadd45a by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation. Leukemia 23:729-738.
38. Perugini M, Iarossi DG, Kok CH, Cummings N et al (2012) Gadd45a methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutation. Leukemia. doi: 10.1038/leu.2012.346.
39. Ramachandran K, Gopisetty G, Gordian E, Navarro L, Hader C, Reis IM, Schulz WA, Singal R (2009) Methylation-mediated repression of GADD45a in prostate cancer and its role as a potential therapeutic target. Cancer Res 69:1527-1535.
40. Regenbrecht CR, Jung M, Lehrach H, Adjaye J (2008) The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines. BMC Med Genomics 1:49.
41. Reimann C, Arola M, Bierings M, Karow A, van den Heuvel-Eibrink MM, Hasle H, Niemeyer CM, Kratz CP (2006) A novel somatic K-Ras mutation in juvenile myelomonocytic leukemia. Leukemia 20:1637-1638.
42. Rothschild TC, Boylan ES, Calhoon RE, Vonderhaar BK (1987) Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats. Cancer Res 47:4508-4516.
43. Salleh MN, Caldwell J, Carmichael PL (2003) A comparison of gene expression changes in response to diethylstilbestrol treatment in wild-type and p53+/-hemizygous knockout mice using focused arrays. Toxicology 185:49-57.
44. Salleh MN, Ismail P, Abdullah AS, Taufiq-Yap YH (2004) Gene expression profiling of p53 (+/-) knockout and wild-type mice following diethylstilbestrol administration. IUMBM Life 56:409-416.
45. Schneider G, Weber A, Zechner U, Oswald F et al (2006) Gadd45a is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability. Int J Cancer 11:2405-2411.
46. Selvakumaran M, Lin HK, Tjin Tham Sjin R, Reed J, Liebermann DA, Hoffman B (1994) The novel primary response gene MyD118 and the proto-oncogenes myb, myc and bcl-2 modulate transforming growth factor b1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol 14:2352-2360.
47. Sowa Y, Hirose T, Takagaki N, Horinaka M, Nakanishi R, Yasuda C, Yoshida T, Kanazawa M, Satomi Y, Nishino H, Miki T, Sakai T (2004) Genistein induces Gadd45 gene and G2/M cell cycle arrest in the DU145 human prostate cancer cell line. FEBS Lett 577:55-59.
48. Sun L, Gong R, Wan B, Huang X, Wu C, Zhang X, Zhao S, Yu L (2003) GADD45g, down-regulated in 65% hepatocellular carcinoma (HCC) from 23 Chinese patients, inhibits cell growth and induces cell cycle G2/M arrest for hepatoma Hep-G2 cell lines. Mol Biol Rep 30:249-253.
49. Sytnikova YA, Kubarenko AV, Schafer A, Weber AN, Niehrs C (2011) Gadd45a is an RNA binding protein and is localized in nuclear speckles. PLoS One 6(1):e14500.
50. Tefferi A, Gilliland DG (2007) Oncogenes in myeloproliferative disorders. Cell Cycle 6:550-566.
51. Tront JS, Hoffman B, Liebermann DA (2006) Gadd45a suppresses ras-driven mammary tumorigenesis by activation of JNK and p38 stress signaling resulting in apoptosis and senescence. Cancer Res 66:8448-8454.
52. Tront JS, Huang Y, Fornace A, Hoffman B, Liebermann DA (2010) Gadd45a promotes or suppresses breast cancer dependent on the oncogenic stress. Cancer Res 70:9671-9681.
53. Tront JS, Willis A, Huang Y, Hoffman B, Liebermann DA (2013) Gadd45a levels in human breast cancer are hormone receptor dependent. J Transl Med 11:131.
54. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, BvWv D, Boer JM et al (2004) Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350:1617-1628.
55. Wang W, Huper G, Guo Y, Murphy SK, Olson JA Jr, Marks JR (2005) Analysis of methylationsensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer. Oncogene 24:2705-2714.
56. Yamasawa K, Noi Y, Dong M, Yamaguchi K, Itakura M (2002) Clinicopathological significance of abnormalities in gadd45 expression and its relationship to p53 in human pancreatic cancer. Clin Cancer Res 8:2563-2569.
57. Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, Ambinder R, Tao Q (2005) The stressresponsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res 11: 6442-6449.
58. Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ Jr, Liebermann DA, Bottinger EP, Roberts AB (2003) TGF-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45B through p38 activation. J Biol Chem 278:43001-43007.
59. Zerbini LF, Wang Y, Czibere A, Correa RG, Cho JY, Ijiri K, Wei W, Joseph M, Gu X, Grall F, Goldring MB, Zhou JR, Libermann TA (2004) NF-kappa B-mediated repression of growth arrest-and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. Proc Natl Acad Sci USA 101:13618-13623.
60. Zerbini LF, de Vasconcellos JF, Czibere A et al (2011) JunD-mediated repression of GADD45a and g regulates escape from cell death in prostate cancer. Cell Cycle 10:2583-2591.
61. Zhan Q, Lord KA, Alamo I Jr, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA, Fornace AJ Jr (1994) The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol 14:2361-2371.
62. Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith K, Hoffman B, Liebermann DA (1999) CR6: A third member in the MyD118 & Gadd45 gene family which functions in negative growth control. Oncogene 18:4899-4907.